| 5-Aminolevulinic Acid studied in …STUDIED_INderived29 of 29show fewer |
|---|
| → studied in | NCT06948552Phase 2 · recruiting Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA · 29 trials list this drug (6 active) | — | — | Renal Pelvis and Ureter Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07828704Phase 2 · recruiting Photodynamic Diagnosis of Kidney Cancer Using Fluorescence Endoscopy and Oral 5-ALA · 29 trials list this drug (6 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02698293Phase 1 · withdrawn PDT Plus Vitamin D3 for Anal Dysplasia · 29 trials list this drug (6 active) | — | — | Carcinoma In Situ,Anal Intraepithelial Neoplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02191488Phase 1 · active not recruiting ALA-induced PpIX Fluorescence During Brain Tumor Resection · 29 trials list this drug (6 active) | — | — | Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05590689Phase 1/Phase 2 · recruiting Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor · 29 trials list this drug (6 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03897491Phase 2 · terminated PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type Glioblastoma · 29 trials list this drug (6 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06417281Phase 3 · completed Photodynamic Diagnosis for Malignant Brain Glioma With 5-Aminolevulinic Acid（5-ALA） · 29 trials list this drug (6 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06665724Phase 1 · completed Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401) · 29 trials list this drug (6 active) | — | — | Anaplastic Astrocytoma,Anaplastic Oligodendroglioma,Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07201376recruiting Assessment of Skin Lesions Using a Tissue Oxygen Imager Based on Protoporphyrin IX (PPIX) Fluorescence. This is an Open-label, Non-randomized, Feasibility Study That Includes a One-time Application of an FDA Approved Medication Followed by Local Imaging for Benign Skin Growth and Lesions Clinically · 29 trials list this drug (6 active) | — | — | Skin Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03048240NA · completed INtraoperative photoDYnamic Therapy of GliOblastoma · 29 trials list this drug (6 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07053852Phase 1 · completed Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage · 29 trials list this drug (6 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04738162Phase 2 · completed Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Brain Tumors · 29 trials list this drug (6 active) | — | — | Childhood Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04391062Phase 2 · completed Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma · 29 trials list this drug (6 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05101798Phase 2 · terminated The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trial · 29 trials list this drug (6 active) | — | — | Neoplasm,Skull Base Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05362409Phase 1 · completed Study to Evaluate 5-ALA Combined With CV01 Delivery of Ultrasound in Recurrent High Grade Glioma · 29 trials list this drug (6 active) | — | — | High-Grade Glioma, NOS | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06160492Phase 3 · recruiting Phase III Clinical Trial Evaluating the Resection Efficacy of 5-Aminolevulinic Acid Hydrochloride (5-ALA HCl) Fluorescence-Guided Microsurgery Versus Conventional White Light Microsurgery in Patients With Malignant Glioma (WHO Grade 3/4) · 29 trials list this drug (6 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06745999Phase 4 · unknown Cryotherapy in Combination with Red Light PDT for Actinic Keratosis of Full Face · 29 trials list this drug (6 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04845919Phase 2 · completed Sonodynamic Therapy With ExAblate System in Glioblastoma Patients · 29 trials list this drug (6 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03963102Phase 4 · terminated Duration of Ameluz Application in Acral Actinic Keratoses Response · 29 trials list this drug (6 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01502280Phase 3 · completed Fluorescence-guided Surgery for Low- and High-grade Gliomas · 29 trials list this drug (6 active) | — | — | Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04055688completed Novel Exoscope System for 5-ALA Fluorescence-Guided Surgery for Gliomas · 29 trials list this drug (6 active) | — | — | Glioma,Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04390802unknown A Pilot Study of 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Pituitary Adenomas · 29 trials list this drug (6 active) | — | — | Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00977795Phase 1/Phase 2 · withdrawn A Study of the Specificity and Sensitivity of 5-ALA Fluorescence in Malignant Brain Tumors · 29 trials list this drug (6 active) | — | — | Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00870779Phase 1 · completed Fluorescence Guided Resection of Brain Tumors · 29 trials list this drug (6 active) | — | — | Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02632370completed 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Malignant Tumor · 29 trials list this drug (6 active) | — | — | Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01502605Phase 1 · terminated Phase I Study of Orally Administered Aminolevulinic Acid for Resection of Malignant Astrocytomas · 29 trials list this drug (6 active) | — | — | Glioma,Astrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02755142Phase 1/Phase 2 · completed Clinical Study on 5-aminolevulinic Acid Hydrochloride (5-ALA) for Fluorescence-guided Resection of Malignant Gliomas · 29 trials list this drug (6 active) | — | — | Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00571974Phase 1/Phase 2 · completed Treatment of Oral Premalignant Lesions With 5-ALA PDT · 29 trials list this drug (6 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00241670Phase 3 · completed Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid · 29 trials list this drug (6 active) | — | — | Brain Neoplasm,Malignant Brain Neoplasm,Primary Brain Tumor | 1 | Observed | clinicaltrials | graph → |